NMC
NEA Management Company Portfolio holdings
AUM
$1.33B
This Quarter Return
+39.88%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.5B
AUM Growth
+$1.5B
(+16%)
Cap. Flow
-$20.9M
Cap. Flow
% of AUM
-1.39%
Top 10 Holdings %
Top 10 Hldgs %
74.88%
Holding
48
New
2
Increased
4
Reduced
2
Closed
4
Top Buys
| 1 |
Korro Bio
KRRO
|
$41.1M |
| 2 |
Synlogic
SYBX
|
$10.2M |
| 3 |
Phathom Pharmaceuticals
PHAT
|
$6.24M |
| 4 |
MYND
Mynd.ai
MYND
|
$1.82M |
| 5 |
IMA
ImageneBio, Inc. Common Stock
IMA
|
$765K |
Top Sells
| 1 |
Mirum Pharmaceuticals
MIRM
|
$69.1M |
| 2 |
ADXN
Addex Therapeutics
ADXN
|
$5.81M |
| 3 |
UTRS
Minerva Surgical, Inc. Common Stock
UTRS
|
$5.66M |
| 4 |
Surf Air Mobility
SRFM
|
$307K |
| 5 |
EAR
Eargo, Inc. Common Stock
EAR
|
$189K |
Sector Composition
| 1 | Healthcare | 78.01% |
| 2 | Consumer Staples | 16.61% |
| 3 | Technology | 3.31% |
| 4 | Industrials | 1.81% |
| 5 | Communication Services | 0.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Coursera
COUR
$1.88B
| $249M | 16.61% | 12,867,769 | – | – |
|
2
Arcellx
ACLX
$3.85B
| $208M | 13.85% | 3,745,262 | – | – |
|
3
Rhythm Pharmaceuticals
RYTM
$6.85B
| $134M | 8.92% | 2,909,956 | – | – |
|
4
Savara
SVRA
$567M
| $115M | 7.67% | 24,471,264 | – | – |
|
|
VRNA
5
Verona Pharma
VRNA
$9.16B
| $111M | 7.4% | 5,108,563 | – | – |
|
6
CRISPR Therapeutics
CRSP
$4.71B
| $99.4M | 6.62% | 1,587,854 | – | – |
|
7
CVRx
CVRX
$205M
| $74.5M | 4.97% | 2,370,542 | – | – |
|
8
Geron
GERN
$893M
| $48.1M | 3.2% | 22,776,409 | – | – |
|
9
Monte Rosa Therapeutics
GLUE
$296M
| $43.5M | 2.9% | 7,692,298 | – | – |
|
|
10
Korro Bio
KRRO
$217M
| $41.1M | 2.74% | +1,072,936 | New | +$41.1M |
|
11
NextNav
NN
$2.37B
| $36.4M | 2.43% | 8,189,156 | – | – |
|
12
Aurinia Pharmaceuticals
AUPH
$1.58B
| $35.7M | 2.38% | 3,969,834 | – | – |
|
13
Nkarta
NKTX
$151M
| $23.6M | 1.57% | 3,568,781 | – | – |
|
14
NeueHealth
NEUE
$59.2M
| $19.9M | 1.32% | 2,726,917 | – | – |
|
15
Sagimet Biosciences
SGMT
$244M
| $18.8M | 1.25% | 3,850,275 | – | – |
|
16
Celcuity
CELC
$2.17B
| $18.2M | 1.21% | 1,250,001 | – | – |
|
|
17
Phathom Pharmaceuticals
PHAT
$864M
| $17.9M | 1.19% | 1,960,169 +683,574 | +54% | +$6.24M |
|
|
ALLK
18
DELISTED
Allakos
ALLK
| $16.8M | 1.12% | 6,147,260 | – | – |
|
|
ZFOX
19
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
| $15.7M | 1.05% | 18,068,513 | – | – |
|
20
Trevi Therapeutics
TRVI
$883M
| $15.2M | 1.02% | 11,370,376 | – | – |
|
21
Gossamer Bio
GOSS
$562M
| $14.5M | 0.96% | 15,838,009 +110,067 | +0.7% | +$100K |
|
|
ADAP
22
Adaptimmune Therapeutics
ADAP
$15.6M
| $13.5M | 0.9% | 17,079,778 | – | – |
|
23
X4 Pharmaceuticals
XFOR
$84.2M
| $12.6M | 0.84% | 14,986,793 | – | – |
|
24
Black Diamond Therapeutics
BDTX
$157M
| $12.5M | 0.83% | 4,448,757 | – | – |
|
|
TUYA
25
Tuya Inc
TUYA
$1.62B
| $11.3M | 0.76% | 4,934,640 | – | – |
|